Clinical trial · Observational
Prostate Volume Changes Following Prostate Brachytherapy With Iodine-125 Seeds
An Observational Study to Evaluate the Changes in Prostate Volume Over Time With The Use of Transrectal Ultrasound and Computed Tomography Following Permanent Prostate Brachytherapy With Iodine-125 Seeds.
NCT00348465CI-TRIAL-00047231completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The size of the prostate changes due to insertion of the radioactive seeds. We will measure the prostate size, before and after the procedure.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Brachytherapy with Iodine-125 seeds | Procedure | — | UNRESOLVED |
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Pathologically confirmed diagnosis of prostate cancer * T1-3 disease * PSA \<20 ng/ml * Patient must sign a study-specific informed consent prior to enrollment. Exclusion Criteria: * Patients ineligible to brachytherapy
References
Publications (0)
Data not yet available
No reference posted for this study.